The Impact of Hospitalization on Ambulatory Blood Pressure and Intraocular Pressure
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to assess the effect of hospital admission on 24-hour ambulatory blood pressure (ABP) in hypertensive subjects.Treated or untreated hypertensive adults with open angle glaucoma underwent in-hospital and outpatient 24-hour ABP monitoring, in random order 4 weeks apart.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
30 Years to 65 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects with untreated ocular hypertension and stage 1 arterial hypertension with or without treatment with anti-hypertensive agents.
age >30 years old.
subject has signed an informed consent.
patient has untreated ocular hypertension (IOP at 10:00 between 22-34 mm Hg)
patient has stage 1 arterial hypertension with or without therapy
stage 2 or 3 hypertension, history of renal disease.
acute or chronic inflammation.
myocardial infarction or unstable angina within the past 6 months.
heart failure NYHA class III-IV.
active liver disease.
history of drug or alcohol abuse, or any other condition with poor prognosis.
treatment with non-steroid anti-inflammatory agents, corticosteroids, beta-blockers, or any other regimen that could affect BP levels.